Artelo Biosciences, Inc. (ARTL) vs Iterum Therapeutics PLC (ITRMF)
- Artelo Biosciences, Inc. ARTL 2.70 −1.46%
- Iterum Therapeutics PLC ITRMF 0.00 NaN
Artelo Biosciences, Inc. and Iterum Therapeutics PLC are both Biotechnology companies. Artelo Biosciences, Inc. and Iterum Therapeutics PLC are of similar size ($1.6M and $1.5M). Artelo Biosciences, Inc. has the higher net margin (0.00% vs −2,930.5%) and the lower return on invested capital (−865.9% vs −455.5%). Across the 13 metrics below, Iterum Therapeutics PLC leads on 7 and Artelo Biosciences, Inc. on 6.
Valuation
Profitability
| Metric | ARTL | ITRMF | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | (81.85%) | 65.16% |
| Operating margin | 0.00% | (2,243.48%) | 0.00% |
| Net margin | 0.00% | (2,930.54%) | 0.00% |
| Free cash flow margin | 0.00% | (2,122.61%) | 0.00% |
| Return on equity | (705.71%) | 285.48% | (56.36%) |
| Return on assets | (234.30%) | (111.35%) | (48.04%) |
| Return on invested capital | (865.85%) | (455.51%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack